Immune Dysregulation in Cancer Patients Undergoing Immune Checkpoint Inhibitor Treatment and Potential Predictive Strategies for Future Clinical Practice-Reference-Cited by-同舟云学术

Immune Dysregulation in Cancer Patients Undergoing Immune Checkpoint Inhibitor Treatment and Potential Predictive Strategies for Future Clinical Practice

Published:2018-03-22 Issue: Volume:8 Page:
ISSN:2234-943X
Container-title:Frontiers in Oncology
language:
Short-container-title:Front. Oncol.

Author:

Anderson Ronald,Rapoport Bernardo L.

Publisher

Frontiers Media SA

Subject

Cancer Research,Oncology

Reference111 articles.

1. Cancer immunotherapy: the beginning of the end of cancer?;Farkona;BMC Med,2016

2. Reactivation of dormant anti-tumor immunity – a clinical perspective of therapeutic immune checkpoint modulation;Greil;Cell Commun Signal,2017

3. The immunogenicity of humanized and fully human antibodies: residual immunogenicity resides in the CDR regions;Harding;mAbs,2010

4. Molecular properties of human IgG subclasses and their implications for designing therapeutic monoclonal antibodies against infectious diseases;Irani;Mol Immunol,2015

5. Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412;Suntharalingam;N Engl J Med,2006

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic strategies targeting CD47-SIRPα signaling pathway in gastrointestinal cancers treatment;Journal of Pharmaceutical Analysis;2024-09

2. Immune‐related adverse events of antibody‐based biological medicines in cancer therapy;Journal of Cellular and Molecular Medicine;2024-07

3. Immunophenotyping of Gastritis, Gastric Ulcer and Gastric Cancer using a Cluster of Differentiation (CD) Antibody Microarray;Sains Malaysiana;2023-01-31

4. Molecular subtypes based on metabolic genes are potential biomarkers for predicting prognosis and immune responses of clear cell renal cell carcinoma;European Journal of Immunology;2022-11-24

5. Antibody Diversity in Cancer: Translational Implications and Beyond;Vaccines;2022-07-22